Literature DB >> 10066525

Multiple antibiotic resistance and efflux.

H Nikaido1.   

Abstract

Multiple antibiotic resistance in bacteria was at first thought to be caused exclusively by the combination of several resistance genes, each coding for resistance to a single drug. More recently, it became clear that such phenotypes are often achieved by the activity of drug efflux pumps. Some of these efflux pumps exhibit an extremely wide specificity covering practically all antibiotics, chemotherapeutic agents, detergents, dyes, and other inhibitors, the exception perhaps being very hydrophilic compounds. Such efflux pumps work with exceptional efficiency in Gram-negative bacteria through their synergistic interaction with the outer membrane barrier. It is disturbing that the antibacterial agents of the most advanced type, which are unaffected by common resistance mechanisms, are precisely the compounds whose use appears to select for multidrug-resistant mutants that overproduce these efflux pumps of wide specificity.

Mesh:

Substances:

Year:  1998        PMID: 10066525     DOI: 10.1016/s1369-5274(98)80083-0

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  86 in total

1.  Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to beta-lactams due to reduced expression of the ampC beta-lactamase.

Authors:  N Masuda; E Sakagawa; S Ohya; N Gotoh; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Purification and ligand binding of EmrR, a regulator of a multidrug transporter.

Authors:  A Brooun; J J Tomashek; K Lewis
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

3.  AcrD of Escherichia coli is an aminoglycoside efflux pump.

Authors:  E Y Rosenberg; D Ma; H Nikaido
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

Review 4.  Mutation frequencies and antibiotic resistance.

Authors:  J L Martinez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

5.  Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance.

Authors:  A Lee; W Mao; M S Warren; A Mistry; K Hoshino; R Okumura; H Ishida; O Lomovskaya
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

6.  Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia.

Authors:  A Alonso; J L Martinez
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

7.  Membrane topology of the multidrug transporter MdfA: complementary gene fusion studies reveal a nonessential C-terminal domain.

Authors:  Julia Adler; Eitan Bibi
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

8.  Activation of multiple antibiotic resistance in uropathogenic Escherichia coli strains by aryloxoalcanoic acid compounds.

Authors:  C Balagué; E G Véscovi
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

9.  Transition to the open state of the TolC periplasmic tunnel entrance.

Authors:  Christian Andersen; Eva Koronakis; Evert Bokma; Jeyanthy Eswaran; Daniel Humphreys; Colin Hughes; Vassilis Koronakis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

10.  The Escherichia coli multidrug transporter MdfA catalyzes both electrogenic and electroneutral transport reactions.

Authors:  Oded Lewinson; Julia Adler; Gerrit J Poelarends; Piotr Mazurkiewicz; Arnold J M Driessen; Eitan Bibi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.